Immune-related genetic prognostic index to predict prognosis and immune checkpoint inhibitor therapy efficiency in acute myeloid leukemia

二维码有效期 120s

作者 Cao Xunhong ^[1] Huang Xiaojun ^[1] Zhao Xiangyu ^[1] 学术成果认领

作者单位 Peking University People’s Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, Beijing 100044, China ^[1]

栏目名称

Correspondence

DOI 10.1097/CM9.0000000000002657

发布时间 2025-04-22

基金项目

National Natural Science Foundation of China（Nos. 81670166, 81870140, 82070184, and 81621001）； Peking University People’s Hospital Research and Development Funds（No. RDL2021-01）； Beijing Life Oasis Public Service Center（No. CARTFR-01）； CSH Young Scholars and 3SBio Pharmaceutical joint research project（No. KYC2201001）

浏览8
被引2
下载0

中华医学杂志英文版

2023年136卷10期

1253-1255页

SCIMEDLINEISTICCSCDCABP

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Immune-related genetic prognostic index to predict prognosis and immune checkpoint inhibitor therapy efficiency in acute myeloid leukemia

Immune-related genetic prognostic index to predict prognosis and immune checkpoint inhibitor therapy efficiency in acute myeloid leukemia

中华医学杂志英文版

相似文献

中华医学杂志英文版

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Immune-related genetic prognostic index to predict prognosis and immune checkpoint inhibitor therapy efficiency in acute myeloid leukemia

Immune-related genetic prognostic index to predict prognosis and immune checkpoint inhibitor therapy efficiency in acute myeloid leukemia

中华医学杂志英文版

相似文献

中华医学杂志英文版

相关期刊

检索历史清除